Clinical trial
Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion - PEOPLE Study
NCT05186324 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion - PEOPLE Study
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 26, 2022
- Completion date
- August 31, 2022
- Enrollment
- 23 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.